Key result
Frailty is linked to a ~42% lower likelihood of OAC prescription in older hospitalized AF patients.
Why the study?
Evidence regarding the impact of frailty on oral anticoagulant prescription in older individuals with atrial fibrillation is conflicting.
Does frailty reduce the prescription of oral anticoagulants in older hospitalized patients with atrial fibrillation?
Cohort (n=685)
Yes
Does frailty reduce the prescription of oral anticoagulants in older hospitalized patients with atrial fibrillation?
In older hospitalized patients with atrial fibrillation, frailty is highly prevalent and independently associated with a reduced likelihood of oral anticoagulant prescription and an increased likelihood of rate-control medication prescription.
Answers are grounded in this paper and cite their sources.
Supports individualized OAC decisions incorporating frailty in older AF inpatients; extends conflicting prior data but remains hypothesis-generating.
Background and aims Evidence of the impact of frailty on oral anticoagulant (OAC) prescription in older people with atrial fibrillation (AF) is conflicting. This study aimed to examine the prevalence of frailty in hospitalised older patients with AF and its relationship with OAC prescription during admission. The secondary aim was to examine the association between frailty and rate/rhythm control medication prescriptions. Methods This retrospective observational study included adults aged ≥65 with AF admitted to six hospitals in Australia in 2022. Frailty was defined by a Frailty Index ≥0.25. Logistic regression models were applied to examine the association between frailty and the prescriptions of OAC, rate-control and rhythm-control drugs during hospitalisation. Results are presented as odds ratios and 95% confidence intervals (CI). Results There were 685 patients, with a mean age of 82.6(SD 8.3), 49.8% female and 42.8% identified as frail. Overall, 75.6% were prescribed OAC (67.9% in the frail versus 81.4% in the non-frail, p<0.001), 37.7% received rate-control drugs (42.0% in the frail versus 34.4% in the non-frail, p=0.044), 27.3% received rhythm-control drugs (22.9% in the frail versus 30.6% in the non-frail, p=0.024). The adjusted odds ratios of frailty on prescriptions were 0.58 (95% CI 0.39-0.86) for OAC, 1.75 (95%CI 1.22-2.52) for rate-control drugs, and 0.83 (95%CI 0.55-1.24) for rhythm-control drugs. Conclusions The study revealed a high prevalence of frailty in older inpatients with AF. Frailty was associated with reduced likelihood of prescription of OAC during admission and increased likelihood of prescribing rate-control medications, with no independent impact on rhythm-control therapy. Further studies are needed to understand these prescribing patterns.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2024) conducted a cohort in Atrial fibrillation (n=685). Frailty vs. Non-frail was evaluated on Prescription of oral anticoagulants (OAC) during hospitalisation (OR 0.58, 95% CI 0.39-0.86, p=<0.001). Frailty was associated with a reduced likelihood of oral anticoagulant prescription during hospital admission in older patients with atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: